DNTH
Price
$24.34
Change
+$0.69 (+2.92%)
Updated
Aug 22, 04:59 PM (EDT)
Capitalization
782.18M
TSHA
Price
$3.00
Change
+$0.13 (+4.53%)
Updated
Aug 22, 04:59 PM (EDT)
Capitalization
782.92M
82 days until earnings call
Interact to see
Advertisement

DNTH vs TSHA

Header iconDNTH vs TSHA Comparison
Open Charts DNTH vs TSHABanner chart's image
Dianthus Therapeutics
Price$24.34
Change+$0.69 (+2.92%)
Volume$9.05K
Capitalization782.18M
Taysha Gene Therapies
Price$3.00
Change+$0.13 (+4.53%)
Volume$63.41K
Capitalization782.92M
DNTH vs TSHA Comparison Chart in %
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. TSHA commentary
Aug 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2025
Stock price -- (DNTH: $24.30 vs. TSHA: $3.00)
Brand notoriety: DNTH and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 100% vs. TSHA: 108%
Market capitalization -- DNTH: $782.18M vs. TSHA: $782.92M
DNTH [@Biotechnology] is valued at $782.18M. TSHA’s [@Biotechnology] market capitalization is $782.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than TSHA.

Price Growth

DNTH (@Biotechnology) experienced а +17.16% price change this week, while TSHA (@Biotechnology) price change was +2.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Reported Earning Dates

TSHA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($783M) and DNTH($782M) have the same market capitalization . DNTH has higher P/E ratio than TSHA: DNTH (3.24) vs TSHA (2.70). TSHA YTD gains are higher at: 65.896 vs. DNTH (8.486). TSHA has higher annual earnings (EBITDA): -91.48M vs. DNTH (-129.49M). TSHA has more cash in the bank: 313M vs. DNTH (257M). DNTH has less debt than TSHA: DNTH (1.33M) vs TSHA (59.6M). TSHA has higher revenues than DNTH: TSHA (8.1M) vs DNTH (4.85M).
DNTHTSHADNTH / TSHA
Capitalization782M783M100%
EBITDA-129.49M-91.48M142%
Gain YTD8.48665.89613%
P/E Ratio3.242.70120%
Revenue4.85M8.1M60%
Total Cash257M313M82%
Total Debt1.33M59.6M2%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHTSHA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DGOCX26.760.01
+0.04%
Davis Opportunity C
FSLSX55.08N/A
N/A
Fidelity Value Strategies
CILGX15.82N/A
N/A
Clarkston Institutional
FITGX22.35N/A
N/A
Fidelity Advisor International Growth M
JHISX13.22-0.05
-0.38%
Janus Henderson VIT Global Sust Eq Ins

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+0.98%
IMNM - DNTH
55%
Loosely correlated
+3.97%
XNCR - DNTH
51%
Loosely correlated
-0.93%
CRNX - DNTH
49%
Loosely correlated
+1.07%
ERAS - DNTH
49%
Loosely correlated
+2.74%
OCUL - DNTH
48%
Loosely correlated
+1.42%
More